Abstract:The number of patients with esophageal cancer treated with curatively intended combined modality strategies such as chemoradiation, either in the neoadjuvant setting followed by surgery or as defini tive treatment, is increasing. Due to the rising incidence of esophageal cancer in combination with improved outcome, in particular due to the addition of neoadjuvant chemoradiation prior to surgery, the prevalence of esophageal cancer survivors will increase significantly [1,2]. Therefore, the absolute number of patients at risk for developing late treatment-related toxicity is rising as well. Radiation-induced cardiac toxicity has been studied particularly in patients treated for breast cancer or Hodgkin’s disease, as this toxicity has been considered most relevant because of their more favorable long-term survival outcome [3,4]. In these patient groups, higher rates of cardiac events and increased cardiac mortality have been observed during long-term follow-up. Recently, a significant relation ship between cardiac radiation dose and the risk of cardiac events was found for breast cancer patients treated with radiotherapy [5]. These data can be used to estimate the risk for cardiac complications as a function of radiation dose and baseline risk. In the treatment of esophageal cancer, the radiation dose to the heart is generally much higher than in the aforementioned patient groups. Assuming that the ‘breast cancer model’ for cardiac events can also be used for esophageal cancer patients, the relative risk on cardiac events will increase more than twofold compared with the baseline risk. As esophageal cancer patients often have several cardiovascular risk factors, the absolute access risk for cardiac events is expected to be much higher than in breast cancer. In a recent literature review on cardiac toxicity in esophageal cancer patients we found an overall risk of severe cardiac events of more than 10% [6]. The most frequently observed clinical side effects were cardiac ischemia, pleural and pericardial effusions and heart failure. These grade III or higher late toxicities occurred relatively soon after treatment, with a median follow-up of 26–57 months, and are thus considered clinically relevant. Given the low cure rates of esophageal cancer in these studies, with 3 years survival rates varying between 22 and 45%, the actuarial rates were not reported, but will be much higher. Moreover, given that survival rates after neoadjuvant chemoradiation and surgery are close to 50% after 5 years, a further increase of severe cardiac toxicity may be expected.

Dermal stiffness governs the topography of the epidermis and the underlying basement membrane in young and old human skin

The Human Epidermal Basement Membrane: A Shaped and Cell Instructive Platform That Aging Slowly Alters

Brevibacterium species as a cause of osteomyelitis in a neonate

A mechanistic view on the aging human skin through ex vivo layer-by-layer analysis of mechanics and microstructure of facial and mammary dermis

Skin aging from the perspective of dermal fibroblasts: the interplay between the adaptation to the extracellular matrix microenvironment and cell autonomous processes

Polyelectrolyte Multilayers Impart Healability to Highly Electrically Conductive Films

Extracellular matrix regulation of fibroblast function: redefining our perspective on skin aging

Cardiac toxicity in the radiation treatment of esophageal cancer: an emerging concern.

Cell Senescence-Independent Changes of Human Skin Fibroblasts with Age

Investigation into the significant role of dermal‐epidermal interactions in skin ageing utilising a bioengineered skin construct

Age-Related Changes in the Fibroblastic Differon of the Dermis: Role in Skin Aging

Dermal Pericytes Exhibit Declined Ability to Promote Human Skin Regeneration with Ageing in 3D Organotypic Culture Models

Age-related changes in dermal collagen physical properties in human skin

Stiffness measurement is a biomarker of skin ageing in vivo

The present status of exfoliative cytology in the diagnosis of gastrointestinal malignancy.

Perlecan expression influences the keratin 15‐positive cell population fate in the epidermis of aging skin

Nucleotide sequence of an isoform of chicken retinoic acid binding protein-beta varying in its A domain.

Restoration of the basement membrane after wounding: a hallmark of young human skin altered with aging

A conserved eEF2 coding variant in SCA26 leads to loss of translational fidelity and increased susceptibility to proteostatic insult.

Age-related changes in the composition of the cornified envelope in human skin

Structure-activity relationship analysis of Pd-PEPPSI complexes in cross-couplings: a close inspection of the catalytic cycle and the precatalyst activation model.